PFE
$24.83
Revenue | $14653Mn |
Net Profits | $2910Mn |
Net Profit Margins | 19.86% |
Pfizer Inc.’s revenue jumped 10.31% since last year same period to $14653Mn in the Q2 2025. On a quarterly growth basis, Pfizer Inc. has generated 6.84% jump in its revenue since last 3-months.
Pfizer Inc.’s net profit jumped 12025% since last year same period to $2910Mn in the Q2 2025. On a quarterly growth basis, Pfizer Inc. has generated -1.92% fall in its net profits since last 3-months.
Pfizer Inc.’s net profit margin jumped 10891.36% since last year same period to 19.86% in the Q2 2025. On a quarterly growth basis, Pfizer Inc. has generated -8.2% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.72 |
EPS Estimate Current Year | 0.72 |
Pfizer Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.72 - a 26.32% jump from last quarter’s estimates.
Pfizer Inc.’s earning per share (EPS) estimates for the current year stand at 0.72.
Earning Per Share (EPS) | 0.78 |
Dividend Per Share (DPS) | 0.43 |
Pfizer Inc.’s earning per share (EPS) jumped 30% since last year same period to 0.78 in the Q2 2025. This indicates that the Pfizer Inc. has generated 30% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Pfizer Inc. declared 0.43 dividend per share during the earnings announcement for Q2 2025.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-03-29 | 0.67 | 0.92 | 37.31% |
2025-08-05 | 0.57 | 0.78 | 36.84% |